In recent years, legumain has been found to be overexpressed in a variety of solid tumor tissues, including colorectal, breast, ovarian, prostate and gastric cancer, and was highly correlated with tumor growth, invasion and metastasis [7–11]. Here, LGMN is linked to neoplasm.